Skip to main content

Table 2 An overview of the clinical and immunological findings of reported cases with DOCK2 deficiency

From: First patient in the Iranian Registry with novel DOCK2 gene mutation, presenting with skeletal tuberculosis, and review of literature

No

Sex

Ethnicity

CON

FH

AOO (m)

AF-Inf

Infection

Other manifestations

Immunological abnormality

DOCK2 mutation/protein

Treatment

Outcome

Refs.

1

M

Lebanese

+

3

3

RSV bronchiolitis, recurrent pneumonia,

Lymphopenia, decreased CD3 +, CD4 + , and CD8 +, decreased IgM level, decreased T-cell response to PHA

p.Y1242Yfs*33

HSCT (myeloablative)

Alive

[3]

2

F

Finnish

 < 24

 < 24

Recurrent otitis media, pneumonia, diarrhea, Varicella, M. avium, and HHV-6 infection

Three episodes of thrombocytopenia

Lymphopenia, decreased CD3 +, CD4 +, CD8 +, and CD19 + cells decreased IgM, increased IgE and IgA, decreased T-cell response to PHA, decreased TREC, Non-protective against tetanus toxoid, PRP, Streptococcus pneumoniae

p.R1104W, p.Q1324*

HSCT (reduced-intensity)

Alive

[3]

3

M

Turkish

 + 

 + 

3

3

Recurrent respiratory tract infections, meningoencephalitis, severe varicella infection, mumps,

Lymphopenia, decreased CD3 +, CD4 +, and CD8 +, decreased T-cell response to PHA, No response to VZV

p.R751S

ND

Dead

[3]

4

M

Turkish

 + 

 < 3

 < 3

Chronic diarrhea, oral moniliasis, recurrent pneumonia with parainfluenza virus type 3 and adenovirus, CMV infection, Klebsiella pneumoniae sepsis

FTT, nodular erythematous lesion at the site of bacille Calmette–Guerin vaccination, hepatomegaly with persistently elevated aminotransferase levels, colitis

Lymphopenia, decreased CD3 +, CD4 +, CD19 +, and NK, decreased IgM level, increased IgA, decreased T-cell response to PHA, decreased TREC, Response to HBV not detectable

p.F744Cfs*27

ND

Dead

[3]

5

M

Hispanic

4

4

Interstitial pneumonia

Rectal fistula

Decreased CD3 +, CD4 +, CD8 +, increased NK cells, increased IgM and IgE, decreased T-cell response to PHA, Response to KLH not detectable

p.P1476L, p.M120Mfs*22

High-dose trimethoprim–sulfamethoxazole, HSCT (myeloablative)

Alive

[3]

6

F

Iranian

 + 

2

2

Septicemia, diarrhea, CMV infection

Seizures

Thrombocytopenia, lymphocytopenia, reduced CD4 +, CD19 +, NK cells, elevated IgM, decreased TREC, T cell response to PHA and T cell response to BCG

c.C3310T, p.R1104W

Antibiotics, antiviral treatment, and IVIG

Dead

[5]

7

M

Moroccan

 + 

 + 

0

0

E.coli pyelonephritis

Ulcerative perianal dermatitis, Omenn syndrome, nephrotic syndrome, ARDS, capillary leak syndrome

Lymphopenia, decreasedCD3 +, CD4 +, CD8 +, CD19 +, and NK, decreased IgM and IgA, Absent TREC, absent T cell response to PHA

c.2704-2 A > C

HSCT, etanercept, tocilizumab, and high-dose steroids

Dead

[12]

8

M

Moroccan

 + 

 + 

2.5

ND

Sepsis, Respiratory, distress, Hepatitis, CMV, Enterovirus, Rhinovirus, and Pneumocystis jiroveci infections

ARDS, Bloody diarrhea Livedo

Lymphopenia, decreased CD3 +, CD4 +, CD8 +, absent T cell response to PHA

c.2704-2 A > C

HSCT

Dead

[12]

9

F

Moroccan

 + 

 + 

0

ND

Influenza A and Rhinovirus infection

Bloody diarrhea

Lymphopenia, decreased CD3 +, CD4 +, CD8 +, CD19 +, and NK

c.2704-2 A > C

HSCT (without conditioning)

Alive

[12]

10

F

ND

 + 

ND

0.5

0.5

Recurrent sinopulmonary infections, CMV viremia

Chronic diarrhea

Decreased CD4 + and IgG level, increased IgM, decreased T cell response to PHA and BCG

c.del 902-1078

IVIG, ganciclovir, HSCT (myeloablative)

Alive

[13]

11

M

ND

 + 

ND

5

5

Recurrent pneumonias, oral candidiasis, sepsis

Chronic diarrhea

Decreased CD4 + and CD19 +, panhypogammaglobulinemia

Phe848fs

IVIG, prophylactic antibiotics

Dead

[13]

12

M

Indian

ND

ND

ND

ND

Otitis media, recurrent pneumonia with atypical mycobacterial and influenza Infections

Decreased CD3 +, decreased IgA and IgM level

c.3430C > T, p.Arg1144Ter

ND

ND

[16]

13

ND

Chinese

ND

ND

ND

ND

ND

ND

Leukopenia, increased CD3 +, CD4 +, and CD8 +, decreased CD19 + and NK, decreased IgM and IgG

c.5335A > T, c.2423 T > C

ND

ND

[14]

14

ND

Chinese

ND

ND

ND

ND

ND

ND

Increased CD19 +, decreased NK, increased IgA and IgG

c.743A > G, c.5048C > T

ND

ND

[14]

15

F

Iranian/Turkish

 + 

 + 

18

18

Pneumonia, otitis media, skeletal tuberculosis

Renal failure, pneumothorax, and seizure

Lymphopenia, decreased CD4 +, increased CD19 +, CD20 +,CD16 +, and CD56 +, decreased IgM, increased IgE, Non-protective against diphtheria toxoid

c.1512delG: p.I505Sfs*28

Antibiotics, antiviral, antifungal, and anti-tuberculosis drugs, peritoneal dialysis

Dead

Our case

  1. No. number, CON. consanguinity, FH family history, AOO age of onset, m months, AF-Inf age of first infection, Ref. reference, ND not determined, RSV respiratory syncytial virus, HSCT hematopoietic stem-cell transplantation, CMV cytomegalovirus, HHV human herpes virus, Ig immunoglobulin, NK natural killer, IVIG intravenous immune globulin, TRECs T cell receptor excision circles, PHA phytohemagglutinin, ARDS acute respiratory distress syndrome, BCG Bacillus Calmette–Guérin, FTT failure to thrive, VZV Varicella-zoster virus, HBV hepatitis B virus, KLH keyhole limpet hemocyanin, PRP polyribosylribitol phosphate